Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Status:
Terminated
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
To determine the 1 year progression-free survival (PFS) of the combination of metformin and
standard chemotherapy in patients with previously untreated advanced or metastatic pulmonary
adenocarcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins